Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Wondering

<< Previous

Bullboard Posts

Next >>

Comment by Raddnaron Jul 19, 2020 11:11pm

130 Views

Post# 31288960

RE:Wondering

First, always skeptical about trading forums, so i’ve never posted here. But, i’ve been following along for about 3 months. Love the positivity most of you have.

In regards to japan - ifenprodil was used. It’s an OTC product and doctors used it to treat covid. At least according to this guy. Here is his Twitter. Can’t confirm anything outside this.

https://twitter.com/hasetohru/status/1273773095858302977?s=21

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing